Correction to “Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer”
Unknown · 2026
Read Correction to “Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer” by Unknown (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13271635.txt.
Description
A peer-reviewed research article from Europe PMC (2026). PMID: 41560375; PMCID: PMC13042878. Wei Zhao1,2,3,#, Qian Hao4,5,#, Yu Gan4,5, Jing Tong4,5, Xiaodan Chen1,2,3, Shuran Tan1,2,3, Ruiwen Ruan6,7, Yingdan Huang4,5, Mingming Cao4,5, Jun Deng6,7, Tao Han8, Getao Shi9, Bo Gao9,*, Yu Zhang1,2,3,*, and Xiang Zhou4,5,10,* 1Department of Gynecology, Xiangya Hospital, Central South University, Changsha, China 2Gynecological Oncology Research and Engineering Center of Hunan Province, Changsha, China 3National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China 4Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University,
Catalog record
| CREATOR | Unknown |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |